5-Azacytidine for the Treatment of Intermediate-2/High Ipss Risk Myelodysplastic Syndromes: Results in 83 Patients from the Italian Patient Named ProgramL. Maurillo,A. Spagnoli,A. Gozzini,N. Cecconi, M. D'Argenio,M. Lunghi,S. Rocco,G. Palumbo, E. Rivellini,M. Genuardi,S. Sibilla,F. Ferrara,G. Mele,N. Filardi,G. Sanpaolo,G. Specchia,A. Tonso,A. Santagostino,M. T. Voso,E. Balleari, V. Cassibba,P. Della Cioppa, C. Mazzone,E. Oliva,L. Ciuffreda,D. Russo,S. Galimberti,O. Villani,F. D'Auria,N. Di Renzo, A. M. D'ArcoHaematologica（2008）引用 23|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
